Equitable selection of participants (representation of minorities and women in research)
Researcher Help: Equitable selection of participants (representation of minorities and women in research)
|
Equitable Selection of Participants |
Sample Answers and Examples |
|---|---|
| General Considerations | Health disparities among racial and ethnic groups have been identified in conditions such as diabetes, cardiovascular disease, HIV/ AIDS, and cancer. The generalizability of such research takes on increased significance in diseases with known disparities. The ethical principle of justice requires the burdens and benefits of research on various populations be fair. In 1993, the United States Congress passed Public Law 103-43 mandating that all NIH funded clinical trials have “appropriate representation” of minority and women subjects. Florida’s state funded biomedical research programs have also adopted similar requirements.
|
| Required Determinations by the IRB | A regulatory criterion for IRB approval is that selection of participants is equitable. Selection of participants is not equitable unless the study includes adequate minority representation, particularly when research concerns conditions where there are known health disparities, unless the investigator can justify any exclusions. |
| Accreditation Element | Element II.5.A: The Research Review Unit has and follows written policies and procedures to evaluate the equitable selection of participants from various populations and sub-populations, when applicable, and considers whether inclusion and exclusion criteria impose fair and equitable burdens and benefits. |
| Regulations | 45 CFR §46.111(a)(3), 21 CFR §56.111(a)(3), OHRP Guidance on Written Institutional Review Board (IRB) Procedures |
| Guidance | |
| References |
|